Grifols, S.A. (GRFS)
NASDAQ: GRFS · Real-Time Price · USD
8.47
-0.16 (-1.85%)
At close: Nov 18, 2026, 4:00 PM EST
8.31
-0.16 (-1.94%)
Pre-market: Nov 19, 2026, 7:00 AM EST
Grifols Revenue
Grifols had revenue of 7.42B EUR in the twelve months ending June 30, 2026, up 2.90% year-over-year. In the year 2025, Grifols had annual revenue of 7.52B with 4.33% growth.
Revenue (ttm)
7.42B EUR
Revenue Growth
+2.90%
P/S Ratio
0.87
Revenue / Employee
296,842 EUR
Employees
25,000
Market Cap
7.50B USD
Revenue by Segment
Fiscal year ended Dec 31, 2025 See the full Grifols breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 7.52B | 312.00M | 4.33% |
| Dec 31, 2024 | 7.21B | 620.02M | 9.41% |
| Dec 31, 2023 | 6.59B | 528.01M | 8.71% |
| Dec 31, 2022 | 6.06B | 1.13B | 22.92% |
| Dec 31, 2021 | 4.93B | -406.92M | -7.62% |
| Dec 31, 2020 | 5.34B | 241.35M | 4.73% |
| Dec 31, 2019 | 5.10B | 611.97M | 13.64% |
| Dec 31, 2018 | 4.49B | 168.65M | 3.91% |
| Dec 31, 2017 | 4.32B | 268.24M | 6.62% |
| Dec 31, 2016 | 4.05B | 115.27M | 2.93% |
| Dec 31, 2015 | 3.93B | 579.18M | 17.26% |
| Dec 31, 2014 | 3.36B | 613.65M | 22.38% |
| Dec 31, 2013 | 2.74B | 120.79M | 4.61% |
| Dec 31, 2012 | 2.62B | 825.33M | 45.96% |
| Dec 31, 2011 | 1.80B | 804.88M | 81.24% |
| Dec 31, 2010 | 990.73M | 77.54M | 8.49% |
| Dec 31, 2009 | 913.19M | 98.88M | 12.14% |
| Dec 31, 2008 | 814.31M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Pfizer | 63.62B |
| AstraZeneca | 62.38B |
| Sanofi | 57.89B |
| Novo Nordisk | 50.70B |
| Bristol-Myers Squibb Company | 50.03B |
| GSK plc | 44.53B |
| Amgen | 38.90B |
| Gilead Sciences | 30.99B |
GRFS News
- 16 days ago - Grifols Q3 Net Profit Rises, Revenue Up 8.4%; On Track To Meet 2026 Guidance - Nasdaq
- 16 days ago - Grifols (GRFS) Q3 2026 Earnings Call Transcript - The Motley Fool
- 16 days ago - Grifols Q3 Earnings Call Highlights - MarketBeat
- 16 days ago - Grifols Earnings Call Transcript: Q3 2026 - Transcripts
- 16 days ago - Grifols Earnings release: Q3 2026 - Filings
- 16 days ago - Grifols Slides: Q3 2026 - Filings
- 24 days ago - Grifols price target lowered to $9 from $10 at JPMorgan - TheFly
- 4 weeks ago - Plasma donation company Grifols begins phased reopening of centres after 2-month hiatus - CBC News